Most Read Articles
Roshini Claire Anthony, 07 Aug 2018

While the use of a mesh for pelvic organ prolapse repair resulted in an elevated risk of repeat surgery compared with native tissue repair, the mesh itself did not influence the need for repeat procedure, according to a US-based study.

Refining the role of combination therapy for the medical management of benign prostatic hyperplasia

15 Jun 2017
At a recent morning tea symposium held in conjunction with the Malaysian Urological Conference 2016, Dr Marie Carmela Lapitan discussed about the benefits of combination therapy with alpha-blockers and 5-alpha-reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia (BPH).

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 07 Aug 2018

While the use of a mesh for pelvic organ prolapse repair resulted in an elevated risk of repeat surgery compared with native tissue repair, the mesh itself did not influence the need for repeat procedure, according to a US-based study.